Leukodystrophies are a heterogenous group of genetic disorders, characterised by abnormal development of cerebral white matter. Pelizaeus-Merzbacher disease is caused by mutations in PLP1, encoding major myelin-resident protein required for myelin sheath assembly. We report a missense variant p.(Ala109Asp) in MAL as causative for a rare, hypomyelinating leukodystrophy similar to Pelizaeus-Merzbacher disease. MAL encodes a membrane proteolipid that directly interacts with PLP1, ensuring correct distribution during myelin assembly. In contrast to wild-type MAL, mutant MAL was retained in the endoplasmic reticulum but was released following treatment with 4-phenylbutyrate. Proximity-dependent identification of wild-type MAL interactants implic...
Pelizaeus-Merzbacher disease (PMD) and spastic paraplegia type 2 (SPG2) are rare X-linked allelic di...
PLP1 is located on the X-chromosome and encodes myelin proteolipid protein (PLP), the most abundant ...
Missense mutations in the human PLP1 gene lead to dysmyelinating diseases with a broad range of clin...
Leukodystrophies are a heterogenous group of genetic disorders, characterised by abnormal developmen...
Pelizaeus–Merzbacher Disease (PMD) is an inherited leukodystrophy affecting the central nervous syst...
Pelizaeus-Merzbacher disease is an X-linked hypomyelinating leukodystrophy caused by mutations or re...
Myelin is a highly specialized membrane unique to the nervous system that ensheaths axons to permit ...
Pelizaeus-Merzbacher disease (PMD) is a form of X-linked leukodystrophy caused by mutations in the p...
Hypomyelinating leukodystrophies are a heterogeneous group of disorders. Simons et al. identify four...
SummaryPelizaeus-Merzbacher disease (PMD) is a form of X-linked leukodystrophy caused by mutations i...
The two proteins, proteolipid protein and DM20, which are encoded by alternative transcripts from th...
In oligodendrocytes (OLGs), an indirect, transcytotic pathway is mediating transport of de novo synt...
Missense mutations in the human PLP1 gene lead to dysmyelinating diseases with a broad range of clin...
In oligodendrocytes (OLGs), an indirect, transcytotic pathway is mediating transport of de novo synt...
Missense mutations in the human PLP1 gene lead to dysmyelinating diseases with a broad range of clin...
Pelizaeus-Merzbacher disease (PMD) and spastic paraplegia type 2 (SPG2) are rare X-linked allelic di...
PLP1 is located on the X-chromosome and encodes myelin proteolipid protein (PLP), the most abundant ...
Missense mutations in the human PLP1 gene lead to dysmyelinating diseases with a broad range of clin...
Leukodystrophies are a heterogenous group of genetic disorders, characterised by abnormal developmen...
Pelizaeus–Merzbacher Disease (PMD) is an inherited leukodystrophy affecting the central nervous syst...
Pelizaeus-Merzbacher disease is an X-linked hypomyelinating leukodystrophy caused by mutations or re...
Myelin is a highly specialized membrane unique to the nervous system that ensheaths axons to permit ...
Pelizaeus-Merzbacher disease (PMD) is a form of X-linked leukodystrophy caused by mutations in the p...
Hypomyelinating leukodystrophies are a heterogeneous group of disorders. Simons et al. identify four...
SummaryPelizaeus-Merzbacher disease (PMD) is a form of X-linked leukodystrophy caused by mutations i...
The two proteins, proteolipid protein and DM20, which are encoded by alternative transcripts from th...
In oligodendrocytes (OLGs), an indirect, transcytotic pathway is mediating transport of de novo synt...
Missense mutations in the human PLP1 gene lead to dysmyelinating diseases with a broad range of clin...
In oligodendrocytes (OLGs), an indirect, transcytotic pathway is mediating transport of de novo synt...
Missense mutations in the human PLP1 gene lead to dysmyelinating diseases with a broad range of clin...
Pelizaeus-Merzbacher disease (PMD) and spastic paraplegia type 2 (SPG2) are rare X-linked allelic di...
PLP1 is located on the X-chromosome and encodes myelin proteolipid protein (PLP), the most abundant ...
Missense mutations in the human PLP1 gene lead to dysmyelinating diseases with a broad range of clin...